The knockdown of CD82 expression in MDA-MB-231 breast cancer cells promoted cell migration and invasion, which was posited to be via the dysregulation of mitogen-activated protein kinase (MAPK) signaling, and the interaction of CD82 with EGFR [48,49]. Here, CD82 is linked to breast cancer.